ERBB2 and cancer: These TAAs are varied and contain a unique group of autologous cellular antigens (10, 25, 26), including the tumor suppressor p53 (27, 28), oncogene products such as HER-2/neu and ras (29), proteins that protect mRNAs from degradation such as p62 (30) and CRD-BP (31), onconeural antigens (32), differentiation-antigens such as tyrosinase and the cancer/testis antigens (33), and anti-apoptotic proteins such as survivin (34) and LEDGF (35).